Criteo S.A.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
CVS Health and Criteo agreed to a $20.5M settlement for alleged data privacy violations. The lawsuit claimed CVS shared patient health data with Criteo via web trackers without consent. The settlement covers U.S. users of CVS digital properties before July 27, 2026, with potential payouts of $5-$10 per class member. CVS and Criteo deny wrongdoing. A final approval hearing is set for Dec. 1.
A US judge is set to approve a $32 million settlement for GoodRx and Criteo, resolving privacy allegations. This is the third iteration of the settlement. Both companies are involved in the case.
Criteo CFO Connor McGogney filed a Rule 144 notice for a 758-share sale to cover tax withholding from restricted stock unit vesting on March 1, 2024, at an indicative price of $17.5004 per share. The filing also lists prior share sales by McGogney over the past three months.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CRTO (Criteo S.A.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent CRTO coverage spans insider activity, regulation and corporate actions.
In the last 30 days, CRTO insiders filed 7 SEC Form 4 transactions — no purchases and 7 sales ($119K). The most active reporter was McGogney Connor, Chief Financial Officer, with 3 filings.
Criteo faces similar reputational risk and may see a slight share dip.
Criteo faces similar risk reduction from settlement approval.
Minor dilution from insider share sale; limited price impact.
The premium bid suggests a potential acquisition, likely driving the stock higher if the deal proceeds.
This is a routine insider sale disclosure with limited direct signal value; it may slightly affect sentiment but does not change fundamentals by itself.
AlphAI scores every news story that mentions CRTO with an AI model for sentiment and relevance, and aggregates insider trades from Criteo S.A.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CVS Health and Criteo agreed to a $20.5M settlement for alleged data privacy violations. The lawsuit claimed CVS shared patient health data with Criteo via web trackers without consent. The settlement covers U.S. users of CVS digital properties before July 27, 2026, with potential payouts of $5-$10 per class member. CVS and Criteo deny wrongdoing. A final approval hearing is set for Dec. 1.
2 min readA US judge is set to approve a $32 million settlement for GoodRx and Criteo, resolving privacy allegations. This is the third iteration of the settlement. Both companies are involved in the case.
1 min readCriteo CFO Connor McGogney filed a Rule 144 notice for a 758-share sale to cover tax withholding from restricted stock unit vesting on March 1, 2024, at an indicative price of $17.5004 per share. The filing also lists prior share sales by McGogney over the past three months.
1 min readCriteo (CRTO) shares rose 21% after receiving a takeover offer from Vista Equity Partners and Quinti Capital, valuing the company at over a 50% premium. The bid is non-public, and details are undisclosed. Criteo's board will review the proposal. Rival Trade Desk (TTD) shares also gained 1%.
2 min readGlickman Sarah JS (Chief Financial Officer) sold 6,285 shares of Criteo S.A. (CRTO) at $17.23 ($0.11M total) on 2026-08-06.
2 min readDamon Ryan (Chief Legal Officer) sold 6,178 shares of Criteo S.A. (CRTO) at $17.23 ($0.11M total) on 2026-08-06.
1 min readKomasinski Michael (CEO) sold 15,559 shares of Criteo S.A. (CRTO) at $17.23 ($0.27M total) on 2026-08-06.
2 min readMorgan Stanley lowered its price target on Criteo S.A. to $25 from $29 while keeping an Equalweight rating, according to the note cited in the article. The update was published Aug. 6, 2026. The change may affect investor expectations for the stock’s valuation.
1 min readCriteo S.A. (CRTO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 5, 2026 Date of Report (Date of earliest event reported) CRITEO S.A. (Exact name of registrant as specifie
4 min readCriteo (CRTO) shares fell as much as 26% after the company reported a third-quarter earnings beat but cut its full-year outlook and gave weaker-than-expected guidance. Its contribution excluding traffic acquisition costs declined 13% to $255 million, a key metric for investors.
1 min read